Engineers at the University of Pennsylvania have built a lipid nanoparticle that chemically fuses an IDO-pathway inhibitor ...
Panel A shows worldwide age-standardized incidence and mortality rates for cervical cancer in 2022. Data are from the GLOBOCAN database and were collated by the International Agency for Research on ...
Transient HPV is the norm, whereas persistent high-risk HPV over years drives cervical dysplasia and malignant transformation, supporting longitudinal surveillance when high-risk types are identified.